Who owns the SINULIEF trademark?

The SINULIEF trademark is owned by RoseWell Pharmaceuticals LLC.

What class is the SINULIEF trademark registered in?

The SINULIEF trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for SINULIEF?

The USPTO serial number for SINULIEF is 98653939.

What is the registration number for SINULIEF?

SINULIEF is registered under USPTO registration number 8234500.

Sealvo

Home Search: SINULIEFSINULIEF #98653939

Back

Updated Sep 16, 2026·33 searches this week

View on USPTO TSDR Find similar marks

SIN

USPTO Trademark Record

REGISTERED

SINULIEF

SN 98653939·Reg 8234500·Filed Jul 17, 2024

Owner RoseWell Pharmaceuticals LLC

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

SINULIEF (Serial No. 98653939), Registration No. 8234500, is a registered US trademark filed on Jul 17, 2024 by RoseWell Pharmaceuticals LLC. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: April 28, 2032

Conflict Analysis

Full conflict analysis for SINULIEF (SN 98653939) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

SINULIEF (Reg. #8234500) is a registered US trademark that has been protecting its owner, RoseWell Pharmaceuticals LLC, since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 17, 2024

SERIAL

98653939

REG#

8234500

REGISTERED

Apr 28, 2026

Filing Information

StatusREGISTERED

Filing DateJul 17, 2024

Serial Number98653939

Registration No.8234500

Registration DateApr 28, 2026

Status DateApr 28, 2026

Published for OppositionSep 16, 2025

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: May 09, 2025

First use in commerce: May 09, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

29 events

REGISTERED-PRINCIPAL REGISTER

Apr 28, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 28, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ASSIGNED TO EXAMINER

Apr 07, 2026

ASSIGNED TO EXAMINER

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Apr 07, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Apr 07, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Mar 27, 2026

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

STATEMENT OF USE PROCESSING COMPLETE

Mar 27, 2026

STATEMENT OF USE PROCESSING COMPLETE

TEAS POST PUBLICATION AMENDMENT RECEIVED

Nov 21, 2025

TEAS POST PUBLICATION AMENDMENT RECEIVED

USE AMENDMENT FILED

Nov 16, 2025

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Nov 16, 2025

TEAS STATEMENT OF USE RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 11, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Sep 16, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 16, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 10, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 15, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

SUSPENSION LETTER WRITTEN

Aug 08, 2025

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Aug 08, 2025

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Aug 08, 2025

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 07, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 07, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 07, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

May 06, 2025

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

May 06, 2025

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

ASSIGNED TO EXAMINER

Feb 07, 2025

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Feb 07, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 07, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 07, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 06, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jul 18, 2024

NEW APPLICATION ENTERED

Other Marks by RoseWell Pharmaceuticals LLC

Additional USPTO filings from the same owner.

ROS

ROSEWELL

98654038

RoseWell Pharmaceuticals LLC

REGISTERED

ZEN

ZENNIX

98653965

RoseWell Pharmaceuticals LLC

ABANDONED

Other Marks by Nathaniel A. Wickliffe

Additional USPTO filings handled by the same attorney of record.

PAT

PATIOPONCHO

98857985

REGISTERED

FLA

FLAVAFIL

79430237

REGISTERED

88223805

REGISTERED

ROS

ROSEWELL

98654038

REGISTERED

SINULIEF

Run a conflict check

Other Marks by RoseWell Pharmaceuticals LLC

Other Marks by Nathaniel A. Wickliffe

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company